Newsroom

Newsroom

NeoGenomics to Present New Data at ESMO 2024, Highlighting the Value of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment

Press Release
Read More

NeoGenomics to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Press Release
Read More

NeoGenomics Reports Second Quarter 2024 Results

Press Release
Read More

Targeting a STING agonist to perivascular macrophages in prostate tumors delays resistance to androgen deprivation therapy

Literature
Read More

NeoGenomics to Report Second Quarter 2024 Financial Results on July 29, 2024

Press Release
Read More

EGFR: Master Regulator of the Oncology Universe

Blog
Read More

Fort Myers’ Mayor to Proclaim June as NeoGenomics’ Commitment to Cancer Month

Press Release
Read More

Comparative analysis of actionable gene reporting in targeted panels versus comprehensive NGS testing for solid tumor samples

Literature
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients